David Ospina, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Mob-b, Ste 3, Berlin, VT 05602 Phone: 802-225-5400 Fax: 802-225-5401 |
News Archive
"For a country that has a large population of heavy smokers, the Italian Government has shown real courage in the fight against passive smoking," said association President Dr Paul Skerritt.
A Finnish study found that the more allergic diseases an individual has, the higher the asthma risk.
European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world's most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.
› Verified 1 days ago